31.08.2018
Eckert & Ziegler Strahlen- und Medizintechnik AG DE0005659700
DGAP-Adhoc: Dr. Lutz Helmke appointed as new director at Eckert & Ziegler Strahlen- und Medizintechnik AG; Dr. André Heß retires from director's position
DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s):
Change of Personnel
Dr. Lutz Helmke appointed as new director at Eckert & Ziegler Strahlen- und
Medizintechnik AG; Dr. André Heß retires from director's position
31-Aug-2018 / 20:44 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation
(EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Berlin, 31 August 2018. Today, the Supervisory Board of Eckert & Ziegler
Strahlen- und Medizintechnik AG appointed Dr. Lutz Helmke as a new member of
the Board of Directors of Eckert & Ziegler Strahlen- und Medizintechnik AG
effective September 17, 2018. Dr. Helmke takes over as member of the Board
of Directors, filling the position of the former director Dr. André Heß,
whose appointment the Supervisory Board revokes effective immediately.
The Supervisory Board of Eckert & Ziegler Strahlen- und Medizintechnik AG
and Dr. Helmke agreed on a director's contract with terms of office until
December 31, 2021.
Contact:
Eckert & Ziegler
Strahlen- und Medizintechnik AG
Karolin Riehle
Investor Relations
Robert-Rössle-Str. 10
13125 Berlin - Germany
Tel.: +49-30-94 10 84 138
Tel.: +49-30-94 10 84 112
E-mail: [email protected]
---------------------------------------------------------------------------
Information and Explanation of the Issuer to this News:
Dr. Helmke will manage Eckert & Ziegler Strahlen- und Medizintechnik AG
together with
Dr. Andreas Eckert as the chairman of the Board of Directors and Dr. Harald
Hasselmann as additional director.
Dr. Helmke, born in 1961, studied Mathematics and Chemistry at FU Berlin.
After graduating from Radio Chemistry studies and receiving his PhD, he
switched to Medical Technology and started his career in the marketing
department of Biotronik. After that, he held various management positions at
Abbott, St. Jude Medical, and most recently MagForce over a period of 25
years. As the head of various task forces within the German Federal
Association for Medical Technology, Dr. Helmke also gained a wide range of
experience in market launches and the reimbursement aspects of medical
products. Dr. Helmke has three children and lives with his family in
Berlin-Charlottenburg.
---------------------------------------------------------------------------
31-Aug-2018 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Eckert & Ziegler Strahlenund Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
Stuttgart, Tradegate Exchange
End of Announcement DGAP News Service
---------------------------------------------------------------------------
719779 31-Aug-2018 CET/CEST
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Eckert & Ziegler Strahlen- und Medizintechnik AG ISIN: DE0005659700 können Sie bei EQS abrufen
Medtech , 565970 , EUZ , XETR:EUZ